Asheesh Kumar

Dr. Asheesh Kumar


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BMBilal Ahmad Mir
Bilal Ahmad Mir
TMTahir Majeed
Tahir Majeed
ASAlka Singh
Alka Singh
MRMahendra Singh Rajput
Mahendra Singh Rajput
AKAsheesh Kumar
Asheesh Kumar
ACAshish Chauhan
Ashish Chauhan
Celiac disease (CeD) is a chronic, immune‐mediated enteropathy that is precipitated by dietary gluten in genetically predisposed individuals expressing HLA‐DQ2 and/or HLA‐DQ8. In the current clinical practice, there are many serologic studies to aid in the diagnosis of CeD which include autoantibodies like IgA antitissue transglutaminase, antiendomysium, and antideamidated forms of gliadin peptide antibodies. Small intestinal biopsy has long been considered an essential step for the diagnosis of CeD. However, in the recent era, researchers have explored the possibility of CeD screening and diagnosis without endoscopy or biopsy. The newer emerging biomarkers of CeD appear promising in diagnostic evaluation and subsequent monitoring of disease. In this review of literature, we have explored the emerging biomarker‐based diagnostic evaluation and monitoring of CeD.

1 January 2023 in Indian Journal of Nephrology
Verified
Journal Article
Open access
AKAsheesh Kumar
Asheesh Kumar
NCNaresh Chauhan
Naresh Chauhan
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society

17 October 2023 in Glomerular Diseases
Verified
Journal Article
Open access
PDF file
AKAsheesh Kumar
Asheesh Kumar
SGSamriti Gupta
Samriti Gupta
KJKush Dev Singh Jarial
Kush Dev Singh Jarial
SSSukhwinder Sangha
Sukhwinder Sangha
ACAshish Chauhan
Ashish Chauhan
DSDheeraj Sharma
Dheeraj Sharma
Introduction: Anti-glomerular basement membrane (anti-GBM) disease is a rare organ-specific autoimmune disease. The overall and renal outcomes of patients have mostly been reported in small-sized cohorts. We aimed to study the clinical profile, overall survival, and renal survival of anti-glomerular basement membrane disease patients at our center. Methods: We conducted a retrospective analysis of the data regarding the clinical profile and renal survival of patients diagnosed with anti-GBM disease from October 2019 to March 2022, having a minimum follow-up of 12 months. Results: There were 15 patients in the study, with the mean age of presentation being 51.6 ± 13.7 years. The median duration of symptoms onset to the nephrologist opinion was 15 (10–23) days. The extrarenal manifestations were seen in the respiratory, otorhinolaryngological, and neurological systems. The mean serum anti-GBM titers were 154.5 (14.9–263.5) U/mL. Serum anti-GBM titers were present in 13/15 (86.6%) patients, and 12/13 (92.3%) patients had above the reference range. Anti-neutrophil cytoplasm antibody (ANCA) levels were assessed in 12/15 (80%) patients, and 9/12 (75%) had higher levels. Renal biopsy was available in 14 patients with more than 50% crescents. Along with crescents, necrotizing lesions, rupture of the Bowman’s capsule, and granulomatous lesions were also seen. Among the initial therapies, the steroid pulse was given to 13 (86.6%) patients, whereas membrane plasmapheresis was given to 8 (53.3%) patients. Inj. cyclophosphamide and inj. rituximab were given to 8 (53.3%) and 4 (26.6%) patients, respectively. No difference was seen in clinical characteristics, renal biopsy features, treatment received, and outcomes with ANCA positivity except for age, where patients who were ANCA positive were older compared to patients who were ANCA negative. One-year renal and patient survival was seen in 4 (26.6%) and 6 (40%) patients, respectively. Conclusion: Most patients of anti-GBM disease have active sediments, raised creatinine, and non-specific symptomatology. There is poor renal and patient outcome as most patients present with advanced renal failure.

3 August 2022 in Kidney and Dialysis
Verified
Journal Article
Open access
PDF file
AKAsheesh Kumar
Asheesh Kumar
RSRam Singh
Ram Singh
TCC placement is a skilled procedure; one must be aware of possible complications, particularly those related to the positioning of catheters, which are vital for the proper functioning of catheters and hemodialysis procedure. It is also equally important to be familiar with the appropriate management if such complications are encountered.

1 January 2023 in Indian Journal of Nephrology
Verified
Journal Article
Open access
AKAsheesh Kumar
Asheesh Kumar
RSRam Singh
Ram Singh
ACAshish Chauhan
Ashish Chauhan
DSDheeraj Sharma
Dheeraj Sharma
RSRajeev Sandal
Rajeev Sandal
BVBalbir Verma
Balbir Verma
COVID-19 was made based on self-reported history of being COVID positive. History of hospitalization and oxygen therapy was noted. Four patients developed COVID-19 in this cohort, and all were infected only once. Two patients had asymptomatic disease and two were hospitalized for severe COVID-19 and had complete recovery. In immunocompromised patients, there is a high risk of infection. This observational study is an attempt to bridge the gap that immunosuppression can precipitate COVID-19 infection....

18 July 2023 in The National Medical Journal of India
Verified
Journal Article
Open access
SGSamriti Gupta
Samriti Gupta
PSPartap Sadan
Partap Sadan
RSRam Singh
Ram Singh
AKAsheesh Kumar
Asheesh Kumar